Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe India | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
  • Argentina | es
  • Brazil | pt
  • Canada | fr
  • Canada | en
  • Central America | es
  • Colombia | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh
  • Austria | de
  • Belgium | nl
  • Belgium | fr
  • Bulgaria | bg
  • Czech Republic | en
  • Czech Republic | cs
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | fr
  • Switzerland | de
  • United Kingdom | en
  • Global | en
  • Novartis Foundation | en
  • Sandoz | en
  • Egypt | en
  • Israel | he
  • South Africa | en
  • Turkey | tr

Language & Country Selector for Mobile

language-selector-globe India

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | nl
  • Belgium | fr
  • Brazil | pt
  • Bulgaria | bg
  • Canada | fr
  • Canada | en
  • Central America | es
  • Colombia | es
  • Czech Republic | en
  • Czech Republic | cs
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Israel | he
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Sandoz | en
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | fr
  • Switzerland | de
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About
      • Novartis in India
      • Global Drug Development
      • Strategy
      • Diversity and Inclusion
      • People and Culture
      • Arogya Parivar
      • India Site Locations
      • NIL Board of Directors
        • Mr. Christopher Snook
        • Mr. Sanjay Murdeshwar
        • Mr. Jai Hiremath
        • Ms. Sandra Martyres
        • Ms. Monaz Noble
        • Mr. Sanker Parameswaran
      • Contact
      About
    • Patients and Caregivers
      • Novartis Commitment to Patients and Caregivers
      • Diseases
      • Adverse Event Reporting
      Patients and Caregivers
    • Healthcare Professionals
      • Healthcare professional country resource
      • Novartis Pipeline
      • Adverse Event Reporting
      • Novartis Clinical Trials
      Healthcare Professionals
    • ESG
      • Ethical Behavior
        • Code of Ethics
        • SpeakUp
      • Ethics, Risk and Compliance
      • Access
      • Environmental Sustainability
      • Global Health
      ESG
    • Investors
      • Annual General Meeting
      • Corporate Policies
      • Financial Results
      • Stock Exchange Disclosures
      • Transfer of Shares to IEPF Demat Account
      • Novartis India Investors Contact
      • Novartis India Annual General Meeting
      • Novartis India Board of Directors
      Novartis India Investors
    • News
      • News Archive
      • Contacts
      News
    • Careers
      • Career Search
      • BioCamp
      • Meet the teams
      • Personal Growth
      • Early Talent
      • Well-being
      • Diversity and Inclusion
      • Awards and Recognition
      Careers
    • Coronavirus
      Coronavirus
    Home
Header
Scientist in a lab

Healthcare Professionals

Providing support and seeking collaboration

Previous Next
Novartis works closely with healthcare professionals around the work to support their treatment of patients and collaborate on unmet needs.
Patient and Doctor at a clinical trial

Clinical Trials

Novartis is working closely with healthcare professionals to bring clinical trials closer.

A scientist with a pipette

Pipeline

COVID-19 information for healthcare professionals Novartis is working closely with healthcare professionals during the coronavirus disease pandemic

A pair of doctors looking at something

Healthcare professional resources by country

Novartis provides information and resources through country HCP portals

Young patients waiting outside hospital in Rwanda

Managed Access

Novartis Managed Access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases

Q2_HP Hero image-edited

Adverse Event Reporting

By reporting side effects for Novartis products you help us to ensure the safety of our products and our patients.

Novartis India

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
  • Contacts
Media Center
  • News Archive
Our Portfolio
  • Novartis Clinical Pipeline
Other Novartis websites
  • Global site
  • Novartis MedHub India
Footer Bottom
© 2022 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Web Accessibility
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in India